NHS urges irregular period checks for PMOS

Up to 4 million women with irregular periods should be investigated for polyendocrine metabolic ovarian syndrome (PMOS) under new NHS guidance, which aims to improve diagnosis and care.

Sublocade to be pulled from Australia by end of 2025

US pharma company Indivior will stop marketing and selling the long-acting injectable opioid Sublocade in Australia from 31 December, citing a commercial decision, causing alarm among doctors and pharmacists.

Page 23 of 258
Pickt mobile sticky banner — logo, tagline and CTA button